Gangliosides -- A new therapeutic agent against stroke and Alzheimer's disease
- 1 January 1994
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 55 (25-26) , 2125-2134
- https://doi.org/10.1016/0024-3205(94)00393-9
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Ganglioside characterization of rat astroglial cells in primary culture: Detection of the ganglio and lacto series gangliosidesNeurochemistry International, 1991
- Human brain gangliosides: developmental changes from early fetal stage to advanced ageBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Comparison of epi-GM3 with GM3 and GM1 as stimulators of neurite outgrowthDevelopmental Brain Research, 1988
- Gangliosides in the nervous system during development and regenerationNeurochemical Pathology, 1986
- Effect of GM1 ganglioside treatment on postlesion responses of cholinergic enzymes in rat hippocampus after various partial deafferentationsJournal of Neuroscience Research, 1984
- Interaction of GM1 ganglioside with PC12 pheochromocytoma cells: Serum‐ and NGF‐dependent effects on neuritic growth (and proliferation)Journal of Neuroscience Research, 1984
- Dorsal root ganglia and nerve growth factor: A model for understanding the mechanism of GM1 effects on neuronal repairJournal of Neuroscience Research, 1984
- Gangliosides enhance neurite outgrowth in PC12 cellsDevelopmental Brain Research, 1983
- THE SITE OF SYNTHESIS OF GANGLIOSIDES IN THE CHICK OPTIC SYSTEMJournal of Neurochemistry, 1979
- FORMATION AND TURNOVER OF THE MAJOR BRAIN GANGLIOSIDES DURING DEVELOPMENT *Journal of Neurochemistry, 1967